Daniel R. Hart
2023
Compensation breakdown
| Non-Equity Incentive Plan | $225,400 |
|---|---|
| Salary | $442,692 |
| Stock Awards | $1,217,152 |
| Other | $51,654 |
| Total | $1,936,898 |
Hart received $1.2M in stock awards, accounting for 63% of the total pay in 2023.
Hart also received $225.4K in non-equity incentive plan, $442.7K in salary and $51.7K in other compensation.
Rankings
In 2023, Daniel R. Hart's compensation ranked 549th out of 2,983 executives tracked by ExecPay. In other words, Hart earned more than 81.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 549 out of 2,983 | 82nd |
Division Manufacturing | 313 out of 1,637 | 81st |
Major group Chemicals And Allied Products | 217 out of 906 | 76th |
Industry group Drugs | 214 out of 869 | 75th |
Industry Pharmaceutical Preparations | 134 out of 627 | 79th |
Pay ratio
| Daniel R. Hart's Pay | $1,936,898 |
|---|---|
| Median Employee's Pay | $104,595 |
| Pay Ratio | 19to 1 |
In 2023, the annual total compensation of Daniel R. Hart was $1,936,898.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $104,595.
The ratio of Daniel R. Hart's pay to the pay of median employee was therefore 19 to one.
Hart's colleagues
We found four more compensation records of executives who worked with Daniel R. Hart at Peregrine Pharmaceuticals in 2023.
News
August 28, 2023
August 29, 2022
August 27, 2021
August 27, 2020
August 21, 2019